These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18684273)

  • 21. Device therapies in the post-myocardial infarction patient with left ventricular dysfunction.
    Kadish AH; Reiffel JA; Naccarelli GV; DiMarco JP
    Am J Cardiol; 2008 Sep; 102(5A):29G-37G. PubMed ID: 18722189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac resynchronization and cardioverter defibrillation therapy in a patient with isolated noncompaction of the ventricular myocardium.
    Okubo K; Sato Y; Matsumoto N; Kunimasa T; Kasama S; Sano Y; Miki T; Iida K; Saito F; Saito S; Hirayama A
    Int J Cardiol; 2009 Aug; 136(3):e66-8. PubMed ID: 18674830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention.
    Costantini O; Hohnloser SH; Kirk MM; Lerman BB; Baker JH; Sethuraman B; Dettmer MM; Rosenbaum DS;
    J Am Coll Cardiol; 2009 Feb; 53(6):471-9. PubMed ID: 19195603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ventricular proarrhythmic effects of atrial fibrillation are modulated by depolarization and repolarization anomalies in patients with left ventricular dysfunction.
    Lemola K; Khan R; Nattel S; Talajic M; Roy D; Guerra PG; Lemola S; Dubuc M; Thibault B; Macle L; Khairy P
    Pacing Clin Electrophysiol; 2009 Jan; 32(1):99-105. PubMed ID: 19140919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic sarcoidosis revealed by ventricular tachycardia: electrocardiography and MRI correspondence.
    Latcu DG; Duparc A; Chabbert V; Labarre D; Mondoly P; Maury P; Delay M
    Pacing Clin Electrophysiol; 2007 Dec; 30(12):1566-70. PubMed ID: 18070316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tachycardia-mediated cardiomyopathy secondary to focal atrial tachycardia: long-term outcome after catheter ablation.
    Medi C; Kalman JM; Haqqani H; Vohra JK; Morton JB; Sparks PB; Kistler PM
    J Am Coll Cardiol; 2009 May; 53(19):1791-7. PubMed ID: 19422986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD? Implantable cardioverter defibrillator implantation guidelines based solely on left ventricular ejection fraction do not apply to adults with congenital heart disease.
    Triedman JK
    Circ Arrhythm Electrophysiol; 2008 Oct; 1(4):307-16; discussion 316. PubMed ID: 19808423
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ventricular tachycardia and ventricular fibrillation.
    Srivathsan K; Ng DW; Mookadam F
    Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):801-9. PubMed ID: 19589116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.
    Pietrasik G; Goldenberg I; McNitt S; Polonsky B; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2009 Apr; 20(4):395-400. PubMed ID: 19017351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device.
    Francisco GM; Sharma S; Dougherty AH; Kantharia BK
    Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microvolt T-wave alternans and the selective use of implantable cardioverter defibrillators for primary prevention: a cost-effectiveness study.
    Filion KB; Xie X; van der Avoort CJ; Dendukuri N; Brophy JM
    Int J Technol Assess Health Care; 2009 Apr; 25(2):151-60. PubMed ID: 19331707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac resynchronization therapy and atrial tachyarrhythmias: a question still searching for an answer.
    Adelstein E; Saba S
    J Am Coll Cardiol; 2008 Feb; 51(6):676-7; author reply 677. PubMed ID: 18261690
    [No Abstract]   [Full Text] [Related]  

  • 34. Left ventricular hypertrabeculation/noncompaction-don't forget the myologist!Concerning the article "Isolated myocardial noncompaction als seltene Ursache einer Synkope im Kindesalter" by Binz G. et al. Z Kardiol 92:1039-1044 (2003).
    Stöllberger C; Finsterer J
    Z Kardiol; 2004 Mar; 93(3):242-3; author reply 243-4. PubMed ID: 15024594
    [No Abstract]   [Full Text] [Related]  

  • 35. [Twiddler syndrome: a rare complication of ICD implantation].
    Waśniewski M; Mitkowski P; Stanek K; Ochotny R; Cieśliński A
    Kardiol Pol; 2007 Sep; 65(9):1094-6. PubMed ID: 17975757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis.
    Rolf S; Haverkamp W; Borggrefe M; Breithardt G; Bocker D
    Europace; 2009 Mar; 11(3):289-96. PubMed ID: 19095687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiarrhythmic effect of reverse ventricular remodeling induced by cardiac resynchronization therapy: the InSync ICD (Implantable Cardioverter-Defibrillator) Italian Registry.
    Di Biase L; Gasparini M; Lunati M; Santini M; Landolina M; Boriani G; Curnis A; Bocchiardo M; Vincenti A; Denaro A; Valsecchi S; Natale A; Padeletti L;
    J Am Coll Cardiol; 2008 Oct; 52(18):1442-9. PubMed ID: 19017510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: the PITAGORA ICD trial.
    Gulizia MM; Piraino L; Scherillo M; Puntrello C; Vasco C; Scianaro MC; Mascia F; Pensabene O; Giglia S; Chiarandà G; Vaccaro I; Mangiameli S; Corrao D; Santi E; Grammatico A;
    Circ Arrhythm Electrophysiol; 2009 Apr; 2(2):146-53. PubMed ID: 19808459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of sleep-disordered breathing on life-threatening ventricular arrhythmia in heart failure patients with implantable cardioverter-defibrillator.
    Serizawa N; Yumino D; Kajimoto K; Tagawa Y; Takagi A; Shoda M; Kasanuki H; Hagiwara N
    Am J Cardiol; 2008 Oct; 102(8):1064-8. PubMed ID: 18929710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial.
    Chow T; Kereiakes DJ; Onufer J; Woelfel A; Gursoy S; Peterson BJ; Brown ML; Pu W; Benditt DG;
    J Am Coll Cardiol; 2008 Nov; 52(20):1607-15. PubMed ID: 18992649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.